Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Yorkie and JNK revert syncytial muscles into myoblasts during Org-1-dependent lineage reprogramming.

Schaub C, Rose M, Frasch M.

J Cell Biol. 2019 Oct 7. pii: jcb.201905048. doi: 10.1083/jcb.201905048. [Epub ahead of print]

PMID:
31591186
2.

Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.

Weller J, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Hau P, Krex D, Grauer O, Goldbrunner R, Bähr O, Uhl M, Seidel C, Tabatabai G, Brehmer S, Bullinger L, Galldiks N, Schaub C, Kebir S, Stummer W, Simon M, Fimmers R, Coch C, Glas M, Herrlinger U, Schäfer N.

Lancet Oncol. 2019 Oct;20(10):1444-1453. doi: 10.1016/S1470-2045(19)30502-9. Epub 2019 Sep 2.

PMID:
31488360
3.

Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.

Kebir S, Schaub C, Junold N, Hattingen E, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Galldiks N, Weller J, Mack F, Tzaridis T, Bähr O, Seidel C, Schlegel U, Schmidt-Graf F, Rohde V, Borchers C, Tabatabai G, Hänel M, Sabel M, Gerlach R, Krex D, Belka C, Vatter H, Proescholdt M, Glas M, Herrlinger U.

J Neurooncol. 2019 Sep;144(3):501-509. doi: 10.1007/s11060-019-03246-4. Epub 2019 Jul 19.

PMID:
31325144
4.

Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.

Tzaridis T, Gepfner-Tuma I, Hirsch S, Skardelly M, Bender B, Paulsen F, Schaub C, Weller J, Schäfer N, Herrlinger U, Tabatabai G.

Neuro Oncol. 2019 Apr 23. pii: noz071. doi: 10.1093/neuonc/noz071. [Epub ahead of print] No abstract available.

PMID:
31089718
5.

Scaling of recovery rates influences T-type Ca2+ channel availability following IPSPs.

Schaub C, Uebachs M.

Heliyon. 2019 Feb 27;5(2):e01278. doi: 10.1016/j.heliyon.2019.e01278. eCollection 2019 Feb.

6.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society.

Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14.

PMID:
30782343
7.

A Large Scale Systemic RNAi Screen in the Red Flour Beetle Tribolium castaneum Identifies Novel Genes Involved in Insect Muscle Development.

Schultheis D, Weißkopf M, Schaub C, Ansari S, Dao VA, Grossmann D, Majumdar U, Hakeemi MS, Troelenberg N, Richter T, Schmitt-Engel C, Schwirz J, Ströhlein N, Teuscher M, Bucher G, Frasch M.

G3 (Bethesda). 2019 Apr 9;9(4):1009-1026. doi: 10.1534/g3.118.200995.

8.

The Effects of Hand Massage on Stress and Agitation Among People with Dementia in a Hospital Setting: A Pilot Study.

Schaub C, Von Gunten A, Morin D, Wild P, Gomez P, Popp J.

Appl Psychophysiol Biofeedback. 2018 Dec;43(4):319-332. doi: 10.1007/s10484-018-9416-2.

9.

Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.

Schaub C, Kebir S, Junold N, Hattingen E, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Niessen M, Mack F, Stuplich M, Tzaridis T, Bähr O, Kortmann RD, Schlegel U, Schmidt-Graf F, Rohde V, Braun C, Hänel M, Sabel M, Gerlach R, Krex D, Belka C, Vatter H, Proescholdt M, Herrlinger U, Glas M.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1581-1589. doi: 10.1007/s00432-018-2671-z. Epub 2018 May 28.

PMID:
29808316
10.

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

Schäfer N, Proescholdt M, Steinbach JP, Weyerbrock A, Hau P, Grauer O, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Grau S, Hänel M, Schnell O, Krex D, Vajkoczy P, Tabatabai G, Mack F, Schaub C, Tzaridis T, Nießen M, Kebir S, Leutgeb B, Urbach H, Belka C, Stummer W, Glas M, Herrlinger U.

Neuro Oncol. 2018 Jun 18;20(7):975-985. doi: 10.1093/neuonc/nox204.

11.
12.
13.

T-Box Genes in Drosophila Mesoderm Development.

Reim I, Frasch M, Schaub C.

Curr Top Dev Biol. 2017;122:161-193. doi: 10.1016/bs.ctdb.2016.06.003. Epub 2016 Jul 30. Review.

PMID:
28057263
14.

The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.

Schaub C, Schäfer N, Mack F, Stuplich M, Kebir S, Niessen M, Tzaridis T, Banat M, Vatter H, Waha A, Herrlinger U, Glas M.

J Cancer Res Clin Oncol. 2016 Aug;142(8):1825-9. doi: 10.1007/s00432-016-2187-3. Epub 2016 Jun 18.

PMID:
27318492
15.

Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.

Schaub C, Tichy J, Schäfer N, Franz K, Mack F, Mittelbronn M, Kebir S, Thiepold AL, Waha A, Filmann N, Banat M, Fimmers R, Steinbach JP, Herrlinger U, Rieger J, Glas M, Bähr O.

J Neurooncol. 2016 Aug;129(1):93-100. doi: 10.1007/s11060-016-2144-7. Epub 2016 May 18.

PMID:
27193554
16.

Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.

Schäfer N, Gielen GH, Kebir S, Wieland A, Till A, Mack F, Schaub C, Tzaridis T, Reinartz R, Niessen M, Fimmers R, Simon M, Coch C, Fuhrmann C, Herrlinger U, Scheffler B, Glas M.

J Cancer Res Clin Oncol. 2016 Jul;142(7):1581-9. doi: 10.1007/s00432-016-2161-0. Epub 2016 Apr 21.

PMID:
27100354
17.

18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.

Kebir S, Gaertner FC, Mueller M, Nelles M, Simon M, Schäfer N, Stuplich M, Schaub C, Niessen M, Mack F, Bundschuh R, Greschus S, Essler M, Glas M, Herrlinger U.

Oncol Lett. 2016 Mar;11(3):2195-2198. Epub 2016 Feb 4.

18.

Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.

Kebir S, Fimmers R, Galldiks N, Schäfer N, Mack F, Schaub C, Stuplich M, Niessen M, Tzaridis T, Simon M, Stoffels G, Langen KJ, Scheffler B, Glas M, Herrlinger U.

Clin Cancer Res. 2016 May 1;22(9):2190-6. doi: 10.1158/1078-0432.CCR-15-1334. Epub 2015 Dec 16.

19.

Zinc regulates a key transcriptional pathway for epileptogenesis via metal-regulatory transcription factor 1.

van Loo KM, Schaub C, Pitsch J, Kulbida R, Opitz T, Ekstein D, Dalal A, Urbach H, Beck H, Yaari Y, Schoch S, Becker AJ.

Nat Commun. 2015 Oct 26;6:8688. doi: 10.1038/ncomms9688.

20.

Org-1-dependent lineage reprogramming generates the ventral longitudinal musculature of the Drosophila heart.

Schaub C, März J, Reim I, Frasch M.

Curr Biol. 2015 Feb 16;25(4):488-94. doi: 10.1016/j.cub.2014.12.029. Epub 2015 Feb 5.

21.

Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.

Doeser A, Dickhof G, Reitze M, Uebachs M, Schaub C, Pires NM, Bonifácio MJ, Soares-da-Silva P, Beck H.

Brain. 2015 Feb;138(Pt 2):371-87. doi: 10.1093/brain/awu339. Epub 2014 Dec 2.

PMID:
25472797
22.

An Org-1-Tup transcriptional cascade reveals different types of alary muscles connecting internal organs in Drosophila.

Boukhatmi H, Schaub C, Bataillé L, Reim I, Frendo JL, Frasch M, Vincent A.

Development. 2014 Oct;141(19):3761-71. doi: 10.1242/dev.111005. Epub 2014 Sep 10.

23.

Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.

Mack F, Schäfer N, Kebir S, Stuplich M, Schaub C, Niessen M, Scheffler B, Herrlinger U, Glas M.

Oncology. 2014;86(5-6):369-72. doi: 10.1159/000360295. Epub 2014 Jun 18.

PMID:
24942787
24.

Maternal inheritance of twist and analysis of MAPK activation in embryos of the polychaete annelid Platynereis dumerilii.

Pfeifer K, Schaub C, Domsch K, Dorresteijn A, Wolfstetter G.

PLoS One. 2014 May 2;9(5):e96702. doi: 10.1371/journal.pone.0096702. eCollection 2014.

25.

FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survival.

Schaub C, Greschus S, Seifert M, Waha A, Blasius E, Rasch K, Landwehr C, Mack F, Schäfer N, Stuplich M, Kebir S, Vilz B, Scheffler B, Boström J, Simon M, Urbach H, Glas M, Herrlinger U.

Oncology. 2013;85(3):191-5. doi: 10.1159/000354692. Epub 2013 Sep 5.

PMID:
24008924
26.

Identification and characterization of a twist ortholog in the polychaete annelid Platynereis dumerilii reveals mesodermal expression of Pdu-twist.

Pfeifer K, Schaub C, Wolfstetter G, Dorresteijn A.

Dev Genes Evol. 2013 Sep;223(5):319-28. doi: 10.1007/s00427-013-0448-6. Epub 2013 Jul 2.

PMID:
23817621
27.

Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity.

Waschbisch A, Atiya M, Schaub C, Derfuss T, Schwab S, Lee DH, Müller M, Linker RA.

J Neurol Sci. 2013 Aug 15;331(1-2):72-5. doi: 10.1016/j.jns.2013.05.012. Epub 2013 Jun 2.

PMID:
23735776
28.

Vemurafenib for leptomeningeal melanomatosis.

Schäfer N, Scheffler B, Stuplich M, Schaub C, Kebir S, Rehkämper C, Mack F, Niehusmann P, Simon M, Greschus S, Kuchelmeister K, Herrlinger U, Glas M.

J Clin Oncol. 2013 Apr 10;31(11):e173-4. doi: 10.1200/JCO.2012.46.5773. Epub 2013 Mar 4. No abstract available.

PMID:
23460716
29.

[The use of touch with a demented elderly resident: multifaceted evidence].

Schaub C, Follonier MC, Borel C, Anchisi A, Kuhne N.

Rech Soins Infirm. 2012 Dec;(111):44-56. French.

PMID:
23409544
30.

Org-1 is required for the diversification of circular visceral muscle founder cells and normal midgut morphogenesis.

Schaub C, Frasch M.

Dev Biol. 2013 Apr 15;376(2):245-59. doi: 10.1016/j.ydbio.2013.01.022. Epub 2013 Feb 1.

31.

Chronic homocysteine exposure causes changes in the intrinsic electrophysiological properties of cultured hippocampal neurons.

Schaub C, Uebachs M, Beck H, Linnebank M.

Exp Brain Res. 2013 Apr;225(4):527-34. doi: 10.1007/s00221-012-3392-1. Epub 2013 Jan 10.

32.

Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.

Jacobi H, Rakowicz M, Rola R, Fancellu R, Mariotti C, Charles P, Dürr A, Küper M, Timmann D, Linnemann C, Schöls L, Kaut O, Schaub C, Filla A, Baliko L, Melegh B, Kang JS, Giunti P, van de Warrenburg BP, Fimmers R, Klockgether T.

Cerebellum. 2013 Jun;12(3):418-28. doi: 10.1007/s12311-012-0421-3.

PMID:
23090211
33.

Behavioral strategies for assessing and promoting community readiness in brain injury rehabilitation.

Schaub C, Peters C, Peters S.

NeuroRehabilitation. 2012;31(1):41-9. doi: 10.3233/NRE-2012-0773. Review.

PMID:
22523010
34.

Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST).

van Loo KM, Schaub C, Pernhorst K, Yaari Y, Beck H, Schoch S, Becker AJ.

J Biol Chem. 2012 May 4;287(19):15489-501. doi: 10.1074/jbc.M111.310763. Epub 2012 Mar 19.

35.

Shear wave ultrasound elastography of the prostate: initial results.

Barr RG, Memo R, Schaub CR.

Ultrasound Q. 2012 Mar;28(1):13-20. doi: 10.1097/RUQ.0b013e318249f594.

PMID:
22357224
36.

Org-1, the Drosophila ortholog of Tbx1, is a direct activator of known identity genes during muscle specification.

Schaub C, Nagaso H, Jin H, Frasch M.

Development. 2012 Mar;139(5):1001-12. doi: 10.1242/dev.073890.

37.

Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients.

Miller AN, Glode A, Hogan KR, Schaub C, Kramer C, Stuart RK, Costa LJ.

Biol Blood Marrow Transplant. 2011 Aug;17(8):1176-81. doi: 10.1016/j.bbmt.2010.12.700. Epub 2010 Dec 23.

38.

Light fields with an axially expanded intensity distribution for stable three-dimensional optical trapping.

Zwick S, Schaub C, Haist T, Osten W.

Opt Express. 2010 Sep 13;18(19):19941-50. doi: 10.1364/OE.18.019941.

PMID:
20940885
39.

HLH54F is required for the specification and migration of longitudinal gut muscle founders from the caudal mesoderm of Drosophila.

Ismat A, Schaub C, Reim I, Kirchner K, Schultheis D, Frasch M.

Development. 2010 Sep;137(18):3107-17. doi: 10.1242/dev.046573.

40.

Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization.

Costa LJ, Miller AN, Alexander ET, Hogan KR, Shabbir M, Schaub C, Stuart RK.

Bone Marrow Transplant. 2011 Apr;46(4):523-8. doi: 10.1038/bmt.2010.170. Epub 2010 Jul 12.

PMID:
20622909
41.

Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization.

Costa LJ, Alexander ET, Hogan KR, Schaub C, Fouts TV, Stuart RK.

Bone Marrow Transplant. 2011 Jan;46(1):64-9. doi: 10.1038/bmt.2010.78. Epub 2010 Apr 12.

PMID:
20383210
42.

Development of prostaglandin endoperoxide synthase expression in the ovine fetal central nervous system and pituitary.

Gersting JA, Schaub CE, Wood CE.

Gene Expr Patterns. 2009 Dec;9(8):603-11. doi: 10.1016/j.gep.2009.08.003. Epub 2009 Aug 23.

43.

Blockade of estrogen action upregulates estrogen receptor-alpha mRNA in the fetal brain.

Schaub CE, Wood CE.

Neonatology. 2009;96(2):115-9. doi: 10.1159/000208793. Epub 2009 Mar 12.

44.

Habituation and short-term repeatability of thermal testing in healthy human subjects and patients with chronic non-neuropathic pain.

Agostinho CM, Scherens A, Richter H, Schaub C, Rolke R, Treede RD, Maier C.

Eur J Pain. 2009 Sep;13(8):779-85. doi: 10.1016/j.ejpain.2008.10.002. Epub 2008 Nov 18.

PMID:
19019713
45.

Inhibition of brain prostaglandin endoperoxide synthase-2 prevents the preparturient increase in fetal adrenocorticotropin secretion in the sheep fetus.

Gersting J, Schaub CE, Keller-Wood M, Wood CE.

Endocrinology. 2008 Aug;149(8):4128-36. doi: 10.1210/en.2008-0123. Epub 2008 May 1.

46.

Development of ER-alpha and ER-beta expression in the developing ovine brain and pituitary.

Schaub CE, Gersting JA, Keller-Wood M, Wood CE.

Gene Expr Patterns. 2008 Jul;8(6):457-63. doi: 10.1016/j.gep.2008.03.001. Epub 2008 Mar 14.

PMID:
18424193
48.

Blockade of estrogen receptors decreases CNS and pituitary prostaglandin synthase expression in fetal sheep.

Schaub CE, Keller-Wood M, Wood CE.

Neuroendocrinology. 2008;87(2):121-8. Epub 2007 Oct 9.

49.

Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.

Schaub C, Uebachs M, Beck H.

Epilepsia. 2007 Jul;48(7):1339-50. Epub 2007 Apr 18. Erratum in: Epilepsia. 2008 Jan;49(1):187.

50.

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values.

Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B.

Pain. 2006 Aug;123(3):231-43. Epub 2006 May 11. Erratum in: Pain. 2006 Nov;125(1-2):197.

PMID:
16697110

Supplemental Content

Loading ...
Support Center